Diagnostic Center | July 18, 2023
PredOmix, Core Diagnostics partner to launch OncoVeryx-F
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)